Zhejiang Longkai Biological Technology Co., Ltd. was established in July 2013. The registered capital is 20 million yuan. It is a technologically innovative industrial company integrating R&D, production and sales. Set up several departments such as medical equipment production, medical equipment, consumables, medical inspection materials (VID) sales, etc., as well as a product research and development room (South Taihu Elite Program Project) and post-doctoral workstations. There are 47 employees, including 4 in clinical medicine (1 doctor), 7 in laboratory medicine, 2 graduates in computer management, 1 graduate in mechanical manufacturing and automation (985,211), and 10 administrative staff. The company has a warehouse area of 400 square meters, including a dedicated cold storage of 50 cubic meters, a cold chain transport vehicle, and a delivery vehicle.

Since its establishment, the company's products have been widely used in medical institutions at all levels. In 2019, it was awarded as an advanced scientific and technological enterprise in Zhejiang Province. In 2018, in order to adapt to the reform of the medical system under the new form, the company specially invited Professor Pan Jianping, a doctoral tutor of Zhejiang University, and Director Chen, the director of the PCR Center Laboratory of Hangzhou First People's Hospital, as our company's senior technical consultants. It provides strong technical support for our company in product development and cooperative development projects of the hospital PCR laboratory. While producing and selling its main products, the company attaches great importance to the research and development of independent brands. In February 2018, the company officially signed a contract with Professor Pan Jianping, Zhejiang University City College School of Medicine, to develop a "vaginal microecological tamponade" product with independent intellectual property rights. In 2020, new disposable masks and the production of disposable collection tubes have laid a solid foundation for the company's product structure adjustment and industrial transformation and upgrading.